Pharma Mar SA
F:PMRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma Mar SA
F:PMRA
|
ES |
|
Littlefield Corp
OTC:LTFD
|
US |
|
Petrotal Corp
XTSX:TAL
|
US |
|
T
|
Tyranna Resources Ltd
ASX:TYX
|
AU |
|
A
|
Altech Chemicals Ltd
F:A3Y
|
AU |
|
B
|
Blue Star Foods Corp
OTC:BSFC
|
US |
|
S
|
Shinyoung HappyTomorrow No.11 Special Purpose Acquisition Company Co Ltd
KOSDAQ:0091W0
|
KR |
|
M
|
MCB Investment Management Ltd
KAR:MCBIM
|
PK |
|
Yamada Consulting Group Co Ltd
TSE:4792
|
JP |
|
Toami Corp
TSE:5973
|
JP |
|
P
|
Proactis SA
PAR:PROAC
|
FR |
|
A
|
Arbor Metals Corp
F:432
|
CA |
|
L
|
Libertas 7 SA
MAD:LIB
|
ES |
|
First Resources Ltd
F:5F1
|
SG |
|
F
|
First Paramount Modaraba
KAR:FPRM
|
PK |
|
S
|
Soneri Bank Ltd
KAR:SNBL
|
PK |
|
Clear Blue Technologies International Inc
F:0YA0
|
CA |
|
Pacific Century Regional Developments Ltd
F:PFQ
|
SG |
|
Public Property Invest ASA
F:6SO
|
NO |
|
B
|
Blende Silver Corp
F:BCW1
|
CA |
|
F
|
Fill Up Media SA
F:X3D
|
FR |
|
A
|
Aecon Group Inc
F:2AE
|
CA |
Wall St Price Targets
PMRA Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for PMRA is 99.26 EUR with a low forecast of 61.52 EUR and a high forecast of 127.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PMRA's stock price target?
Price Target
99.26
EUR
According to Wall Street analysts, the average 1-year price target for PMRA is 99.26 EUR with a low forecast of 61.52 EUR and a high forecast of 127.58 EUR.
What is the Revenue forecast for Pharma Mar SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Pharma Mar SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharma Mar SA?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 27%.
What is the Pre-Tax Income forecast for Pharma Mar SA?
Projected CAGR
38%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 38%.
What is the Net Income forecast for Pharma Mar SA?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 19%.
